Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE9A | O76083 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.48 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.44 |
| ▸ | HTR3A | P46098 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29152127 | 0.88 | ALDH1A1 (0.54) | PDE9AALDH1A1KDM4EHSD17B10ALOX15 | |
| SCHEMBL16984845 | 0.87 | ALDH1A1 (0.55) | PDE9AALDH1A1KDM4EHSD17B10ALOX15 | |
| SCHEMBL1034013 | 0.85 | ALDH1A1 (0.53) | PDE9AALDH1A1KDM4EHSD17B10ALOX15 | |
| SCHEMBL12681373 | 0.82 | ALDH1A1 (0.55) | PDE9AALDH1A1KDM4EHSD17B10ALOX15 | |
| SCHEMBL12679798 | 0.82 | ALDH1A1 (0.55) | PDE9AALDH1A1KDM4EHSD17B10ALOX15 | |
| SCHEMBL13170775 | 0.77 | TSHR (0.54) | PDE9AMEN1KMT2A | |
| SCHEMBL22140560 | 0.77 | HTR3A (0.45) | PDE9AALDH1A1KDM4EHSD17B10ALOX15 | |
| SCHEMBL28428018 | 0.77 | SQOR (0.50) | PDE9AALDH1A1KDM4EHSD17B10MAPT | |
| SCHEMBL5012665 | 0.77 | PDE9A (0.46) | PDE9AALDH1A1KDM4EHSD17B10ALOX15 | |
| SCHEMBL29354925 | 0.76 | ACHE (0.56) | ALDH1A1KDM4EMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7322927-B2 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2008-01-29 | — | — | US | disclosed |
| US-20060228748-A1 | Hybrid phthalocyanine derivatives and their uses | BIOSITE INCORPORATED | 2006-10-12 | — | — | US | disclosed |
| US-7083984-B2 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2006-08-01 | — | — | US | disclosed |
| US-6964844-B1 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2005-11-15 | — | — | US | disclosed |
| US-20020061602-A1 | Hybrid phthalocyanine derivatives and their uses | GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT | 2002-05-23 | — | — | US | disclosed |
| EP-0670041-B1 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS | BIOSITE DIAGNOSTICS INC (US) | 2002-01-30 | — | — | EP | disclosed |
| EP-0820489-B1 | HYBRID PHTHALOCYANINE DERIVATIVES AND THEIR USES | BIOSITE DIAGNOSTICS INC (US) | 2001-07-11 | — | — | EP | disclosed |
| US-6251687-B1 | PARTICLE CONTAINING ENERGY DONOR AND ENERGY ACCEPTOR | BIOSITE DIAGNOSTICS, INC. | 2001-06-26 | — | — | US | disclosed |
| US-5824799-A | A SILICON FLUORESCENT DYES FOR DETECTING ANALYTE IN IMMUNOASSAYS | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1998-10-20 | — | — | US | disclosed |
| US-5763189-A | Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1998-06-09 | — | — | US | disclosed |
| EP-0820489-A1 | HYBRID PHTHALOCYANINE DERIVATIVES AND THEIR USES | BIOSITE DIAGNOSTICS INC. (US) | 1998-01-28 | — | — | EP | disclosed |
| EP-0670041-A4 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS. | BIOSITE DIAGNOSTICS INC (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996029367-A1 | HYBRID PHTHALOCYANINE DERIVATIVES AND THEIR USES | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1996-09-26 | — | — | WO | disclosed |
| EP-0670041-A1 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS | BIOSITE DIAGNOSTICS INC. (US) | 1995-09-06 | — | — | EP | disclosed |
| WO-1995008772-A1 | FLUORESCENCE ENERGY TRANSFER AND INTRAMOLECULAR ENERGY TRANSFER IN PARTICLES USING NOVEL COMPOUNDS | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1995-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060228748-A1 | Hybrid phthalocyanine derivatives and their uses | UACA, PHAX, PTBP1 | PDE9A 3113/4885ALDH1A1 1368/4885KDM4E 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.